XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Background (Details)	Mar. 07, 2023
CARISMA Therapeutics Inc, Legacy, Stockholders | Sesen Bio, Inc. | Carisma Therapeutics Inc.
Background
Common stock at an exchange ratio	1.8994

X

- Definition

Ratio of converted into shares common stock at an exchange ratio.

+ References

No definition available.

+ Details

Name:	carm_ConvertedIntoSharesCommonStockAtExchangeRatio
Namespace Prefix:	carm_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationSegmentAllocationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	dei_LegalEntityAxis=carm_CarismaTherapeuticsIncLegacyStockholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=carm_SesenBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=carm_CarismaTherapeuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: